| Schedule of basic and diluted earnings (loss) per share |
|
|
|
|
|
|
| |
|
Three Months Ended July 31, |
|
| |
|
2025 |
|
|
2024 |
|
| |
|
|
|
|
|
|
| Earnings per share |
|
|
|
|
|
|
|
|
| Net income (loss) |
|
$ |
(8,360,096 |
) |
|
$ |
23,421,355 |
|
| Less: Accretion of discounts to redemption of Series B convertible preferred stock |
|
|
– |
|
|
|
(2,148,047 |
) |
| Less: Series B convertible preferred stock dividends |
|
|
– |
|
|
|
(685,801 |
) |
| Less: Allocation of undistributed income to Series B convertible preferred stock |
|
|
– |
|
|
|
(5,629,949 |
) |
| Net income (loss) attributable to common stockholders |
|
$ |
(8,360,096 |
) |
|
$ |
14,957,558 |
|
| |
|
|
|
|
|
|
|
|
| Weighted average shares outstanding used in basic and diluted earnings per share |
|
|
6,795,779 |
|
|
|
7,866,387 |
|
| Net income (loss) per share basic and diluted |
|
$ |
(1.23 |
) |
|
$ |
1.90 |
|